المؤلفون: Neubauer, M.C., Nicolas, G.P., Bauman, A., Fani, M., Nitzsche, E., Afshar-Oromieh, A., Forrer, F., Rentsch, C., Stenner, F., Templeton, A., Schäfer, N., Wild, D., Chirindel, A.

المساهمون: all investigators on behalf of the SSNM Therapy Working Group, all investigators on behalf of the, Ssnm Therapy Working Group (ed.)

المصدر: European journal of nuclear medicine and molecular imaging, vol. 51, no. 4, pp. 1185-1193

مصطلحات موضوعية: Male, Humans, Prostate-Specific Antigen, Prostatic Neoplasms, Castration-Resistant/diagnostic imaging, Castration-Resistant/radiotherapy, Castration-Resistant/drug therapy, Switzerland, Single Photon Emission Computed Tomography Computed Tomography, Treatment Outcome, Heterocyclic Compounds, 1-Ring/therapeutic use, Lutetium/therapeutic use, Dipeptides/therapeutic use, Retrospective Studies, Urea/analogs & derivatives, Metastatic prostate cancer, Quantitative SPECT/CT, Response monitoring, [177Lu]Lu-PSMA I&T

وصف الملف: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/38038755; info:eu-repo/semantics/altIdentifier/eissn/1619-7089; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_27BF9821DF635; https://serval.unil.ch/notice/serval:BIB_27BF9821DF63; https://serval.unil.ch/resource/serval:BIB_27BF9821DF63.P001/REF.pdf

الاتاحة: https://serval.unil.ch/notice/serval:BIB_27BF9821DF63
https://doi.org/10.1007/s00259-023-06536-2
https://serval.unil.ch/resource/serval:BIB_27BF9821DF63.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_27BF9821DF635

المؤلفون: Khreish, Fadi, Ghazal, Zaidoon, Marlowe, Robert J., Rosar, Florian, Sabet, Amir, Maus, Stephan, Linxweiler, Johannes, Bartholomä, Mark, Ezziddin, Samer

المصدر: http://lobid.org/resources/99370678071406441#!, 49(3):1075-1085.

مصطلحات موضوعية: Heterocyclic Compounds, 1-Ring/adverse effects [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Aged [MeSH], Humans [MeSH], Prospective Studies [MeSH], Prostate-Specific Antigen [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Everyday practice, Lutetium/therapeutic use [MeSH], Original Article, Metastatic castration-resistant prostate cancer (mCRPC), Lutetium-177-PSMA-617 radioligand therapy (, Male [MeSH], “Real-world” data, Dipeptides/adverse effects [MeSH], Radioisotopes [MeSH], Prostate-specific membrane antigen (PSMA), Registries [MeSH], Castration-Resistant/radiotherapy [MeSH]

Relation: https://repository.publisso.de/resource/frl:6451485; https://doi.org/10.1007/s00259-021-05525-7; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803625/

الاتاحة: https://repository.publisso.de/resource/frl:6451485
https://doi.org/10.1007/s00259-021-05525-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803625/

المؤلفون: Huang, Kai, Schatka, Imke, Rogasch, Julian M. M., Lindquist, Randall L., De Santis, Maria, Erber, Barbara, Radojewski, Piotr, Brenner, Winfried, Amthauer, Holger

المصدر: http://lobid.org/resources/99370676563706441#!, 35(3):314-320.

مصطلحات موضوعية: Glutamate Carboxypeptidase II/metabolism [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Radioligand therapy, Treatment Outcome [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antigens, Surface/metabolism [MeSH], Predictive score, Lutetium/therapeutic use [MeSH], Original Article, Male [MeSH], Radioisotopes/therapeutic use [MeSH], Metastatic castration-resistant prostate cancer, Castration-Resistant/radiotherapy [MeSH]

Relation: https://repository.publisso.de/resource/frl:6471492; https://doi.org/10.1007/s12149-020-01567-3; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902572/

الاتاحة: https://repository.publisso.de/resource/frl:6471492
https://doi.org/10.1007/s12149-020-01567-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902572/

المؤلفون: Michalski, Kerstin, Ruf, Juri, Goetz, Christian, Seitz, Anna Katharina, Buck, Andreas K., Lapa, Constantin, Hartrampf, Philipp

المصدر: http://lobid.org/resources/99370678071406441#!, 48(6):2024-2030.

مصطلحات موضوعية: Heterocyclic Compounds, 1-Ring [MeSH], PET/CT, Oncology – Genitourinary, Humans [MeSH], FDG, Radioligand therapy, Positron Emission Tomography Computed Tomography [MeSH], PSMA, Fluorodeoxyglucose F18 [MeSH], Original Article, Ligands [MeSH], Male [MeSH], Prostatic Neoplasms, Castration-Resistant/diagnostic imaging [MeSH], Dipeptides [MeSH], Prognosis [MeSH], Prostate cancer, Castration-Resistant/radiotherapy [MeSH]

Relation: https://repository.publisso.de/resource/frl:6470332; https://doi.org/10.1007/s00259-020-05160-8; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113196/

الاتاحة: https://repository.publisso.de/resource/frl:6470332
https://doi.org/10.1007/s00259-020-05160-8
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113196/

المؤلفون: Seifert, Robert, Kessel, Katharina, Schlack, Katrin, Weckesser, Matthias, Bögemann, Martin, Rahbar, Kambiz

المصدر: http://lobid.org/resources/99370678071406441#!, 47(9):2106-2112.

مصطلحات موضوعية: Heterocyclic Compounds, 1-Ring/adverse effects [MeSH], Oncology – Genitourinary, Humans [MeSH], Prospective Studies [MeSH], Radioligand therapy, Treatment Outcome [MeSH], Retrospective Studies [MeSH], Original Article, VISION Trial, Male [MeSH], Dipeptides/adverse effects [MeSH], mCRPC, Prostatic Neoplasms, Castration-Resistant/radiotherapy [MeSH]

Relation: https://repository.publisso.de/resource/frl:6470230; https://doi.org/10.1007/s00259-020-04703-3; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338828/

الاتاحة: https://repository.publisso.de/resource/frl:6470230
https://doi.org/10.1007/s00259-020-04703-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338828/